Global Intravenous Solutions Market to Reach $20.51 Billion by 2029, Growing at 8% CAGR

What Is the Expected Size and Growth Rate of the Intravenous Solutions Market?
The intravenous solutions market will grow from $14 billion in 2024 to $15.05 billion in 2025, reflecting a CAGR of 7.5%. The growth is attributed to the rise in surgical procedures, growing prevalence of chronic diseases, expansion of home healthcare, stringent regulations ensuring product safety, and increased focus on patient hydration.

The Intravenous Solutions market will grow to $20.51 billion by 2029 at a CAGR of 8.0%, driven by population growth, surgical interventions, and telemedicine. Trends include parenteral nutrition, pre-mixed solutions, and smart IV systems.

What Factors Are Fueling Growth in the Intravenous Solutions Market?
The increasing prevalence of cancer is expected to propel the growth of the intravenous solutions market. Cancer is a group of diseases characterized by uncontrolled cell growth, with the ability to invade surrounding tissues and spread throughout the body. Intravenous solutions are commonly used in cancer treatment to deliver chemotherapy drugs and maintain hydration during therapy. For instance, in February 2024, the World Health Organization projected that by 2050, more than 35 million new cancer cases would be diagnosed, representing a 77% increase compared to 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the intravenous solutions market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

Which Leading Companies Are Shaping the Growth of the Intravenous Solutions Market?
Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

What Are the Latest Innovations in the Intravenous Solutions Market?
Leading firms in the intravenous solutions market are concentrating on the development of innovative syringes, such as pre-filled and ready-to-administer syringes, to gain a competitive advantage. These syringes are preloaded with medication, eliminating the need for manual preparation and reducing the risk of errors. For example, in August 2023, GENIXUS Corp., a US-based healthcare company, introduced KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. Made of a transparent, durable polymer, these syringes eliminate risks associated with traditional glass syringes. Designed for intravenous use only, they include RFID-enabled tracking through KitCheck technology, intuitive labeling, and a color-coded plunger rod to enable quick identification and enhance safety.

What Are the Key Segments of the Intravenous Solutions Market?
The intravenous solutions market covered in this report is segmented -

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients
3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution
4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

Which Region Dominates the Intravenous Solutions Market?
North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Intravenous Solutions Global Market Report?

- Market Size Analysis: Analyze the Intravenous Solutions Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Intravenous Solutions Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Intravenous Solutions Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Intravenous Solutions Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.